Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

9.44
Delayed Data
As of 2:59pm ET
 +0.44 / +4.89%
Today’s Change
6.51
Today|||52-Week Range
11.31
+2.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-27.9M-18.3M4.8M-18.2M
 
 
 
 
 
Depreciation1.1M1.2M649.0K2.2M
 
 
 
 
 
Total Other Cash Flow1.8M-10.3M-20.4M1.5M
 
 
 
 
 
Funds From Operations-25.0M-27.4M-15.0M-14.5M
 
 
 
 
 
Funds From/For Other Operating Expenses2.6M-2.3M1.8M4.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-27.6M-25.1M-16.8M-19.4M
 
 
 
 
 
 
InvestingCapital Expenditures-676.0K-141.0K-39.0K-522.0K
 
 
 
 
 
Fixed Asset Disposal----149.0K--
 
 
Other Investing - Uses0.000.00-1.3M0.00
 
 
Other Investing - Sources0.000.001.1M0.00
 
 
Net Cash Flow Investing-1.0M-433.0K-160.0K-600.0K
 
 
 
 
 
 
FinancingShort Term Borrowings----0.000.00--
Long Term Borrowings--25.0M0.0012.0M
 
 
 
Long Term Debt Reduction---7.0M-13.0M0.00
 
 
 
Net Proceeds Stock Sale358.0K0.008.0K12.6M
 
 
 
 
Common Preferred Redeemed----0.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.0070.0K0.000.00
 
 
Other Uses - Financing0.000.000.002.5M
 
 
Net Cash Flow - Financing358.0K18.1M-13.0M22.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash26.0K84.0K-99.0K-120.0K
 
 
 
 
 
 
Net Change In Cash-28.3M-7.5M-29.9M2.0M